Tag: EX1

Exopharm ASX EX1 publishes results exosome Plexaris Cevaris BioMAP

Exopharm publishes ‘positive and unique’ results for its exosome platform

Regenerative medicine company Exopharm (ASX: EX1) has received amiable results from a BioMAP testing program operated by Eurofins with respect to its exosome products. Results...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS